During the past decade, Osp. SS Filippo Nicola conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Osp. SS Filippo Nicola" are "Stroke" (2 trials), "Atrial Fibrillation" (1 trials) and "Secondary Prevention" (1 trials). Many other conditions were trialed in "Osp. SS Filippo Nicola" in a lesser frequency.

Most popular intervention types in "Osp. SS Filippo Nicola" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "dabigatran etexilate" (1 trials), "optional ASA as comedication" (1 trials), "placebo to ASA" (1 trials) and "placebo to dabigatran etexilate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osp. SS Filippo Nicola" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Osp. SS Filippo Nicola". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Osp. SS Filippo Nicola, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osp. SS Filippo Nicola, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".